Palisade Bio, Inc. (PALI)
1.675
-0.06
(-3.74%)
USD |
NASDAQ |
Jun 09, 15:44
Palisade Bio SG&A Expense (Quarterly) : 4.351M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 27.80M |
| Praxis Precision Medicines, Inc. | 27.87M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |
| Alnylam Pharmaceuticals, Inc. | 322.55M |
| Savara, Inc. | 15.57M |